GOLD BOND ULTIMATE PSORIASIS RELIEF CREAM- salicylic acid lotion 
Chattem, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Gold Bond Ultimate Multi-Symptom Psoriasis Relief Cream

Gold Bond Ultimate 
Multi-Symptom Psoriasis Relief Cream

Drug Facts

Active ingredient

Salicylic acid 3%

Purposes

Psoriasis, Seborrheic Dermatitis

Uses

For relief of skin itching, irritation, redness, flaking and scaling associated with psoriasis and/or seborrheic dermatitis, and to help prevent symptom recurrence

Warnings

For external use only

Ask a doctor before use if

  • condition covers a large area of the body

When using this product

  • avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

  • condition worsens or does not improve after regular use of this product as directed

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

Apply to affected areas one to four times daily or as directed by a doctor

Inactive ingredients

water, hydroxyethyl urea, petrolatum, aminomethyl propanol, glycerin, dimethicone, gluconolactone, steareth-21, jojoba esters, glyceryl stearate, stearyl alcohol, aloe barbadensis leaf juice, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, butyrospermum parkii (shea) butter extract, methyl gluceth-20, 7-dehydrocholesterol, bisabolol, ceteareth-25, zea mays (corn) oil, zingiber officinale (ginger) root extract, ceramide NP, hydrolyzed jojoba esters, cetearyl alcohol, stearamidopropyl PG-dimonium chloride phosphate, magnesium ascorbyl phosphate, panthenol, tocopheryl acetate, ceramide EOP, pentylene glycol, ceramide EOS, bis-lauryl cocaminopropylamine/HDI/PEG-100 copolymer, cholesterol, propylene glycol, caprooyl phytosphingosine, polysorbate 60, ceramide NS, cetyl alcohol, isohexadecane, ethylhexylglycerin, 4-t-butylcyclohexanol, ceramide AP, EDTA, behenic acid, butylene glycol, caprooyl sphingosine, methylparaben, tocopherol

PRINCIPAL DISPLAY PANEL

GOLD BOND
ULTIMATE
Multi-Symptom
Psoriasis
Relief Cream
Net wT 4 oz (113 g)

PRINCIPAL DISPLAY PANEL GOLD BOND ULTIMATE Multi-Symptom Psoriasis Relief Cream Net wT 4 oz (113 g)

GOLD BOND ULTIMATE PSORIASIS RELIEF CREAM 
salicylic acid lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-0412
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID3 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
HYDROXYETHYL UREA (UNII: MBQ7DDQ7AR)  
PETROLATUM (UNII: 4T6H12BN9U)  
AMINOMETHYLPROPANOL (UNII: LU49E6626Q)  
GLYCERIN (UNII: PDC6A3C0OX)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
GLUCONOLACTONE (UNII: WQ29KQ9POT)  
STEARETH-21 (UNII: 53J3F32P58)  
HYDROGENATED JOJOBA OIL, RANDOMIZED (UNII: Q47ST02F58)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) (UNII: 86FQE96TZ4)  
SHEA BUTTER (UNII: K49155WL9Y)  
METHYL GLUCETH-20 (UNII: J3QD0LD11P)  
7-DEHYDROCHOLESTEROL (UNII: BK1IU07GKF)  
LEVOMENOL (UNII: 24WE03BX2T)  
CETEARETH-25 (UNII: 8FA93U5T67)  
CORN OIL (UNII: 8470G57WFM)  
GINGER (UNII: C5529G5JPQ)  
CERAMIDE 3 (UNII: 4370DF050B)  
HYDROLYZED JOJOBA ESTERS (ACID FORM) (UNII: UDR641JW8W)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
STEARAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE (UNII: W6000VEI5Y)  
MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5)  
PANTHENOL (UNII: WV9CM0O67Z)  
ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
CERAMIDE 1 (UNII: 5THT33P7X7)  
PENTYLENE GLYCOL (UNII: 50C1307PZG)  
CERAMIDE EOS (UNII: CR0J8RN66K)  
CHOLESTEROL (UNII: 97C5T2UQ7J)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
POLYSORBATE 60 (UNII: CAL22UVI4M)  
CERAMIDE 2 (UNII: C04977SRJ5)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
ISOHEXADECANE (UNII: 918X1OUF1E)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
4-TERT-BUTYLCYCLOHEXANOL (UNII: K0H1405S9C)  
CERAMIDE 6 II (UNII: F1X8L2B00J)  
EDETIC ACID (UNII: 9G34HU7RV0)  
BEHENIC ACID (UNII: H390488X0A)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
N-HEXANOYLSPHINGOSINE (UNII: 038753E78J)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
TOCOPHEROL (UNII: R0ZB2556P8)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41167-0412-221 g in 1 TUBE; Type 0: Not a Combination Product08/01/2016
2NDC:41167-0412-5113 g in 1 TUBE; Type 0: Not a Combination Product08/01/2016
3NDC:41167-0412-699 g in 1 TUBE; Type 0: Not a Combination Product01/01/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart358H08/01/2016
Labeler - Chattem, Inc. (003336013)

Revised: 8/2022
Document Id: 756937fe-d2b3-4b3e-b01d-c066dc077ae0
Set id: b03e9f03-90f8-4f8c-9365-308931b08d1e
Version: 3
Effective Time: 20220804
 
Chattem, Inc.